![Simon Ostergaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Ostergaard
Corporate Officer/Principal at
Agilent Technologies Sweden AB
Net worth: 65 307 $ as of 31/05/2026
Profile
Simon Ostergaard currently works at Agilent Technologies Sweden AB, as Vice President & GM-Global Pathology Business.
Dr. Ostergaard also formerly worked at CellaVision AB, as President & Chief Executive Officer from 2021 to 2026.
Dr. Ostergaard received his Masters Business Admin degree from Macquarie Graduate School of Management Pty Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELLAVISION AB 0.02% | 30/12/2024 | 5,000 ( 0.02% ) | 65 307 $ | 31/05/2026 |
Simon Ostergaard active positions
| Companies | Position | Start |
|---|---|---|
Agilent Technologies Sweden AB | Corporate Officer/Principal | - |
Former positions of Simon Ostergaard
| Companies | Position | End |
|---|---|---|
| CELLAVISION AB | Chief Executive Officer | 05/06/2026 |
Training of Simon Ostergaard
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
CellaVision AB
 CellaVision AB Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
Agilent Technologies Sweden AB | |
Macquarie Graduate School of Management Pty Ltd.
 Macquarie Graduate School of Management Pty Ltd. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Simon Ostergaard
Choose MarketScreener 
